Mucopolysaccharidosis VI

Mucopolysaccharidosis VI

Introduction: Mucopolysaccharidosis VI (MPS VI) is the result of the absence of arylsulfatase B leading to the abnormal lysosomal accumulation of glycosaminoglycans. Two different phenotypes have been described to date, namely, rapidly progressive and slowly progressive. Aim: To present the evolutio...

Full description

Bibliographic Details
Main Authors:	Juan Politei MD, Andrea Beatriz Schenone MD, Cabrera Gustavo MD, Antacle Alejandra MD, Szlago Marina MD
Format:	Article
Language:	English
Published:	SciELO 2015-02-01
Series:	Journal of Inborn Errors of Metabolism and Screening
Online Access:	https://doi.org/10.1177/2326409814567130

Similar Items

Long-Term Galsulfase Treatment Associated With Improved Survival of Patients With Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome)
by: Adrian Quartel MD, et al.
Published: (2018-01-01)

Mucopolysaccharidosis VI
by: Harmatz Paul, et al.
Published: (2010-04-01)

Vertebrobasilar Dolichoectasia in Fabry Disease
by: Juan Politei, et al.
Published: (2014-06-01)

Small Fiber Neuropathy in Fabry Disease: a Review of Pathophysiology and Treatment
by: Juan M. Politei MD, et al.
Published: (2016-07-01)

Posterior spinal fusion for scoliosis in mucopolysaccharidosis I (Hurler syndrome)
by: Masashi Uehara, MD, et al.
Published: (2019-12-01)

Fabry disease: the importance of the enzyme replacement therapy (TRE), treating quickly and efficiently
by: Juan Manuel Politei, et al.
Published: (2014-06-01)

Carpal Tunnel Syndrome in the Setting of Mucopolysaccharidosis II (Hunter Syndrome)
by: Anne E. Argenta, MD, et al.
Published: (2017-08-01)

Expert Opinions on Managing Fertility and Pregnancy in Patients With Mucopolysaccharidosis
by: Fiona Stewart MB, BS, et al.
Published: (2016-09-01)

Diagnostic and treatment strategies in mucopolysaccharidosis VI
by: Vairo F, et al.
Published: (2015-10-01)

Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
by: Tomoaki Sasaki, MD, PhD, et al.
Published: (2021-03-01)

Hematopoietic Stem Cell Transplantation in Mucopolysaccharidosis Type II
by: Anneliese L. Barth MD, PhD, et al.
Published: (2018-05-01)

Editorial Letter to Special Issue Fabry Disease
by: Juan Politei MD
Published: (2016-07-01)

Mucopolysaccharidosis
by: Nicole Ruas Guarany PhD, et al.
Published: (2015-11-01)

Alder-Reilly Anomaly in Patients with Mucopolysaccharidosis VI
by: Taiane Alves Vieira, et al.
Published: (2008-09-01)

A Case Report of Mucopolysaccharidosis Type VI
by: SJ Hosseini, et al.
Published: (2018-12-01)

Cardiac Manifestation of Fabry Disease
by: Adrián Fernández MD, et al.
Published: (2016-07-01)

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
by: Roberto Giugliani, et al.
Published: (2010-01-01)

Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics
by: Abdellah Tebani, et al.
Published: (2019-01-01)

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
by: Aneesh Karir, et al.
Published: (2018-06-01)

Cuando las enfermedades metabólicas se confunden con las inflamatorias
by: Juan Politei, et al.
Published: (2017-03-01)

A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
by: Barbara Zapała, et al.
Published: (2020-12-01)

The Central Nervous System Involvement in Fabry Disease
by: Alessandro Burlina MD, PhD, et al.
Published: (2016-07-01)

Musculoskeletal manifestations of mucopolysaccharidosis type VI and effects of enzyme replacement therapy
by: Marucha Jolanta, et al.
Published: (2012-04-01)

Pseudoglaucoma em mucopolissacaridose tipo VI: relato de caso Pseudo-glaucoma in type VI mucopolysaccharidosis: case report
by: Miguel Gustavo Rosa da Rocha Canêdo, et al.
Published: (2006-12-01)

Growth Plate Pathology in the Mucopolysaccharidosis Type VI Rat Model—An Experimental and Computational Approach
by: Johana M. Guevara-Morales, et al.
Published: (2020-05-01)

Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI
by: Emine Azak, et al.
Published: (2019-10-01)

Respiratory Dysfunction in Children and Adolescents with Mucopolysaccharidosis Types I, II, IVA, and VI
by: Assel Tulebayeva, et al.
Published: (2020-01-01)

Surgical treatment of craniovertebral stenosis in patients with mucopolysaccharidosis type I, II, and VI
by: Sergey P. Mironov, et al.
Published: (2018-12-01)

Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential
by: Bruno Duarte Gomes, et al.
Published: (2012-03-01)

Can Macrosomia or Large for Gestational Age Be Predictive of Mucopolysaccharidosis Type I, II and VI?
by: Agnieszka Różdżyńska-Świątkowska, et al.
Published: (2016-06-01)

Combined mucopolysaccharidosis type VI and congenital adrenal hyperplasia in a child: Anesthetic considerations
by: Abhishek Bansal, et al.
Published: (2012-01-01)

A Self-Narrative Research on Interpersonal Interactive Experience of A Girl with Mucopolysaccharidosis VI
by: Weng, Yu-Han, et al.
Published: (2018)

Enzyme replacement therapy interruption in mucopolysaccharidosis type IVA patients and its impact in different clinical outcomes
by: Juan Politei, et al.
Published: (2021-03-01)

Human pulmonary artery endothelial cells in the model of mucopolysaccharidosis VI present a prohypertensive phenotype
by: Adam Golda, et al.
Published: (2015-06-01)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
by: Chaitanya Gadepalli, et al.
Published: (2021-07-01)

Case Report: Stage VI Morel-Lavallée Lesion with a Large Challenging Defect
by: Gregory Nicolas, MD, et al.
Published: (2021-04-01)

Impact of Enzyme Replacement Therapy in a Patient Younger Than 2 Years Diagnosed With Maroteaux-Lamy Syndrome (MPS VI)
by: Johanna Acosta Guio MD, et al.
Published: (2017-07-01)

Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
by: Eugeni Entchev, et al.
Published: (2020-01-01)

Level of independence, functional capacity and respiratory muscle strength of patients with mucopolysaccharidosis type VI in the Northeast of Brazil
by: Bárbara Bernardo Rinaldo da Silva Figueirêdo, et al.

Mutational analysis of ARSB gene in mucopolysaccharidosis type VI: identification of three novel mutations in Iranian patients
by: Nasrin Malekpour, et al.
Published: (2018-09-01)

Cannot write session to /tmp/vufind_sessions/sess_752kccho85iemur6sj904e77a5